Primer: Halozyme Therapeutics (HALO US) - Aug 2026
Halozyme's core value proposition is its proprietary ENHANZE® drug delivery technology, which enables the conversion of intravenous therapies to...
92 Views
𝛼SK or SearchENTITY
Halozyme Therapeutics (HALO US)
Halozyme Therapeutics (HALO US)
28
Analysis
Health Care • United States
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
morex